CBL and breast cancer: The findings imply that CIN85 and CBL, two well-known growth factor receptor signaling inhibitors, may be actively involved in tumor invasion and that the role of AMAP1 in breast cancer cell invasion is mediated by intricate epigenetic mechanisms (Yang et al., 1991).